SCHEMBL4564904

SCHEMBL4564904

Cc1[nH]c(C)c(-c2c[nH]c(-c3ccccc3C(F)(F)F)cc2=O)c(=O)c1Cl

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 6/20 0.35
TRPA1 O75762 1/20 0.35
STK10 O94804 3/20 0.35
SLK Q9H2G2 3/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
NPY5R Q15761 1/20 0.34
KIT P10721 1/20 0.34
PIK3C3 Q8NEB9 2/20 0.33
FFAR1 O14842 1/20 0.33
NOTUM Q6P988 1/20 0.33
PDE10A Q9Y233 1/20 0.32
C1R P00736 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4489339 0.87 SLC2A1 (0.41) HSD11B1TRPA1NPY5RKITPIK3C3
SCHEMBL4473579 0.85 PIM1 (0.41) KDM4EMEN1ALDH1A1GLAGAA
SCHEMBL4491166 0.84 POLB (0.37) KITFFAR1
SCHEMBL4565035 0.82 TNKS (0.39) ALDH1A1NPY5R
SCHEMBL4472776 0.81 BIRC5 (0.38) MEN1KMT2A
SCHEMBL4491224 0.81 DAO (0.34) MEN1ALDH1A1KMT2A
SCHEMBL4486317 0.81 MAPT (0.35) KDM4EALDH1A1NOTUM
SCHEMBL4485647 0.81 HSD11B1 (0.35) HSD11B1MEN1ALDH1A1HPGDKMT2A
SCHEMBL4493449 0.79 HCAR2 (0.37) FFAR1
SCHEMBL4475367 0.78 ADORA2A (0.39) KDM4EMEN1ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US claimed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US claimed
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
EP-1858876-A2 PYRIDINONE DERIVATIVES AGAINST MALARIA GLAXO GROUP LIMITED (GB) 2007-11-28 EP disclosed
WO-2006094799-A2 PYRIDINONE DERIVATIVES AGAINST MALARIA GLAXO GROUP LIMITED (GB) 2006-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP HSD11B1 1661/4885TRPA1 3367/4885STK10 2052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.